Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD6UY
|
||||
| Drug Name |
2-{1-[(S)-2-Hydroxy-3-(1H-indol-4-yloxy)-propyl]-piperidin-4-yl}-benzo[b]thiophen-7-ol
|
||||
| Synonyms |
CHEMBL301272
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H26N2O3S
|
||||
| Canonical SMILES |
O[C@H](COc1cccc2[nH]ccc12)CN3CCC(CC3)c4cc5cccc(O)c5s4
|
||||
| InChI |
InChI=1S/C24H26N2O3S/c27-18(15-29-22-6-2-4-20-19(22)7-10-25-20)14-26-11-8-16(9-12-26)23-13-17-3-1-5-21(28)24(17)30-23/h1-7,10,13,16,18,25,27-28H,8-9,11-12,14-15H2/t18-/m0/s1
|
||||
| InChIKey |
LKRVLHRSQXBLNK-SFHVURJKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.